1. Home
  2. MBBC vs HOWL Comparison

MBBC vs HOWL Comparison

Compare MBBC & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

N/A

Current Price

$13.25

Market Cap

33.5M

Sector

Finance

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.66

Market Cap

29.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBBC
HOWL
Founded
1902
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
29.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MBBC
HOWL
Price
$13.25
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
3.1K
423.0K
Earning Date
02-11-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$7,936,063.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.79
N/A
Revenue Growth
21.07
N/A
52 Week Low
$9.34
$0.53
52 Week High
$13.75
$2.38

Technical Indicators

Market Signals
Indicator
MBBC
HOWL
Relative Strength Index (RSI) 60.72 47.92
Support Level $12.75 $0.59
Resistance Level $13.75 $0.74
Average True Range (ATR) 0.15 0.07
MACD 0.04 0.01
Stochastic Oscillator 65.99 31.78

Price Performance

Historical Comparison
MBBC
HOWL

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: